Adicet Bio, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Adicet Bio, Inc. (ACET) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.77 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.66M shares, a 37.52% increase year-over-year.
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 1.21M shares, a 91.07% decline year-over-year.
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 13.50M shares, a 53.65% increase year-over-year.
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 8.79M shares.
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 810.31K shares, a 17.34% decline from fiscal 2024.
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 980.31K shares, a 90.03% decline from fiscal 2023.
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 9.84M shares, a 53.69% increase from fiscal 2022.
- Adicet Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.40M shares, a 31.49% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.77M shares 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | 1.66M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 810.31K shares 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | 18.30M shares 10-Q · filed 2025-11-05 | |||||||
| 2025-06-30 | 1.19M shares 10-Q · filed 2026-08-05 | 19.09M shares 10-Q · filed 2025-08-07 | ||||||
| 2025-03-31 | 1.21M shares 10-Q · filed 2026-05-13 | 19.28M shares 10-Q · filed 2025-05-06 | ||||||
| 2024-12-31 | 980.31K shares 10-K · filed 2026-03-12 | 15.68M shares 10-K · filed 2025-03-06 | ||||||
| 2024-09-30 | 16.46M shares 10-Q · filed 2025-11-05 | |||||||
| 2024-06-30 | 16.94M shares 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | 13.50M shares 10-Q · filed 2025-05-06 | |||||||
| 2023-12-31 | 9.84M shares 10-K · filed 2025-03-06 | |||||||
| 2023-09-30 | 10.34M shares 10-Q · filed 2024-11-06 | |||||||
| 2023-06-30 | 9.01M shares 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | 8.79M shares 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | 6.40M shares 10-K · filed 2024-03-19 | |||||||
| 2022-09-30 | 6.18M shares 10-Q · filed 2023-11-08 | |||||||
| 2022-06-30 | 6.29M shares 10-Q · filed 2023-08-09 | |||||||
| 2021-12-31 | 4.87M shares 10-K · filed 2023-03-15 | |||||||
| 2021-09-30 | 4.50M shares 10-Q · filed 2022-11-08 | |||||||
| 2021-06-30 | 4.66M shares 10-Q · filed 2022-08-10 | |||||||
| 2021-03-31 | 4.99M shares 10-Q · filed 2021-05-17 | |||||||
| 2020-12-31 | 3.93M shares 10-K · filed 2022-03-15 | |||||||
| 2020-09-30 | 14.12M shares 10-Q · filed 2021-11-10 | 3.50M shares 10-Q · filed 2020-11-05 | ||||||
| 2020-06-30 | 14.12M shares 10-Q · filed 2021-08-12 | 2.80M shares 10-Q · filed 2020-07-30 | ||||||
| 2020-03-31 | 14.12M shares 10-Q · filed 2021-05-17 | 3.06M shares 10-Q · filed 2020-05-07 | ||||||
| 2019-12-31 | 14.13M shares 10-K · filed 2021-03-12 | 3.39M shares 10-K · filed 2020-03-12 | ||||||
| 2019-09-30 | 13.59M shares 10-Q · filed 2020-11-05 | 2.30M shares 10-Q · filed 2019-11-05 | ||||||
| 2019-06-30 | 1.73M shares 10-Q · filed 2020-07-30 | 2.09M shares 10-Q · filed 2019-08-14 | ||||||
| 2019-03-31 | 1.73M shares 10-Q · filed 2020-05-07 | 1.71M shares 10-Q · filed 2019-05-15 | ||||||
| 2018-12-31 | 6.67M shares 10-K · filed 2021-03-12 | 1.15M shares 10-K · filed 2020-03-12 | ||||||
| 2018-09-30 | 692.55K shares 10-Q · filed 2019-11-05 | 1.07M shares 10-Q · filed 2018-11-13 | ||||||
| 2018-06-30 | 667.59K shares 10-Q · filed 2019-08-14 | 752.85K shares 10-Q · filed 2018-08-09 | ||||||
| 2018-03-31 | 667.59K shares 10-Q · filed 2019-05-15 | |||||||
| 2017-09-30 | 6.18M shares 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | 4.24M shares 10-Q · filed 2018-08-09 | |||||||
| 2017-03-31 | 2.02M shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |